Search results
Results from the WOW.Com Content Network
Clinical neuroscience is a branch of neuroscience that focuses on the scientific study of fundamental mechanisms that underlie diseases and disorders of the brain and central nervous system. [1] It seeks to develop new ways of conceptualizing and diagnosing such disorders and ultimately of developing novel treatments.
Helmuth began her writing career as a staff reporter and editor for Science magazine, from 1999 to 2004. [8] She then became a Science Editor at Smithsonian Magazine, where she remained from 2004 to 2012 before becoming the Science and Health editor at the online magazine Slate.
Writing in CNN Money's Fortune magazine, John Simons sums up the main thrust of Satisfaction by quoting Berns: "The sense of satisfaction after you've successfully handled unexpected tasks or sought out unfamiliar, physically and emotionally demanding activities is your brain's signal that you're doing what nature designed you to do."
With 179 years in print so far, Scientific American says it’s the “oldest continuously published magazine” in the United States and has published pieces from more than 200 Nobel winners.
The book is a collection of stories of doctors and patients showing that the human brain is capable of undergoing change, including stories of recovering use of paralyzed body parts, deaf people learning to hear, and others getting relief from pain using exercises to retrain neural pathways.
A neuroscientist (or neurobiologist) is a scientist specializing in neuroscience that deals with the anatomy and function of neurons, neural circuits, and glial cells, and their behavioral, biological, and psychological roles in health and disease.
The results of that randomized clinical trial, conducted at 84 sites in the United States from September 2019 to May 2024, are now presented in two studies published Wednesday in the journal Brain ...
David Eagleman (born April 25, 1971) is an American neuroscientist, author, and science communicator.He teaches neuroscience at Stanford University [1] and is CEO and co-founder of Neosensory, a company that develops devices for sensory substitution. [2]